SNS-032

· Sunesis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SNS-032, covering 2012-06-07 to 2017-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies [Phase 1]